Merkoša sitáhtat
APA-čujuhus (7. p.)
Jones, M. E., Sahm, D. F., Martin, N., Scheuring, S., Heisig, P., Thornsberry, C., . . . Schmitz, F. (2000). Prevalence of gyrA, gyrB, parC, and parE Mutations in Clinical Isolates of Streptococcus pneumoniae with Decreased Susceptibilities to Different Fluoroquinolones and Originating from Worldwide Surveillance Studies during the 1997-1998 Respiratory Season. Antimicrob Agents Chemother.
Kopierejuvvon čuohpusbeavdái
Kopieren čuohpusbeavdái ii lihkostuvvan
Chicago-čujuhus (17. p.)
Jones, Mark E., Daniel F. Sahm, Nele Martin, Sibylle Scheuring, Peter Heisig, Clyde Thornsberry, Karl Köhrer, juo Franz-Josef Schmitz. "Prevalence of GyrA, GyrB, ParC, and ParE Mutations in Clinical Isolates of Streptococcus Pneumoniae with Decreased Susceptibilities to Different Fluoroquinolones and Originating from Worldwide Surveillance Studies During the 1997-1998 Respiratory Season."
Antimicrob Agents Chemother 2000.
Kopierejuvvon čuohpusbeavdái
Kopieren čuohpusbeavdái ii lihkostuvvan
MLA-čujuhus (9. p.)
Jones, Mark E., et al. "Prevalence of GyrA, GyrB, ParC, and ParE Mutations in Clinical Isolates of Streptococcus Pneumoniae with Decreased Susceptibilities to Different Fluoroquinolones and Originating from Worldwide Surveillance Studies During the 1997-1998 Respiratory Season."
Antimicrob Agents Chemother, 2000.
Kopierejuvvon čuohpusbeavdái
Kopieren čuohpusbeavdái ii lihkostuvvan
Muitte dárkkistit čujuhemiid riektatvuođa, ovdal go geavahat daid iežat deavsttas.